Arma Angle
  • Homepage
  • About Arma
  • Sector Expertise
  • Capabilities
  • Global Reach
  • Deals
  • Team
  • Arma Angle
  • News
  • Careers
  • Social Impact
  • Contact

Home / Private Equity Raises The Heart Rate Of The HealthTech Revolution

Private Equity Raises The Heart Rate Of The HealthTech Revolution

Share This Article

Scroll

Home / Arma Angle / Private Equity Raises The Heart Rate Of The HealthTech Revolution

Read Arma’s view on the proliferation of technology within healthcare and the subsequent uptick in investment being poured into the industry in full on Forbes here.

The importance of the healthcare industry cannot be emphasised enough. Its impact on people’s wellbeing, its universal relevance around the world and its major economic impact are almost unparalleled among other global industries.

But the industry as a whole is facing challenges, ranging from ageing populations to pressure on government subsidies. Some have speculated that technological advancements such as data analytics, cloud-based IT infrastructure and AI are the solution to the industry’s problems.

However, both the difficulties facing the healthcare industry, and the ambition to find technological solutions, are longstanding realities within the industry. Hospitals and health services have been slower at adopting technology due to strict regulation surrounding its procurement in the public sector, resulting in technological advancement outpacing the speed at which it is adopted.

The healthcare industry’s impact on people’s wellbeing, its universal relevance around the world and its major economic impact are almost unparalleled among other global industries.

As such, the most successful HealthTech companies tend to be those that can curate their products to cater to specific needs, incorporate themselves into existing systems and demonstrate prompt return on investment.

Investment in the healthcare industry shows no signs of stopping.

This year we have seen venture capital and private equity investment being poured into European HealthTech businesses, with Arma playing an active role in advising on these transactions. The likes of Allocate Software and Datix in the UK, Maincare in France and Prospitalia in Germany all received private equity backing, demonstrating the vast investor appetite for best-in-class technology and healthcare companies.

Investment in the healthcare industry shows no signs of stopping. With ageing populations and stretched healthcare budgets, the need for technology within the industry will grow. A combination of these factors reveals an attractive opportunity for investors in the HealthTech sector in the coming years.

The most successful HealthTech companies tend to be those that can curate their products to cater to specific needs, incorporate themselves into existing systems and demonstrate prompt return on investment.

Arma Partners logo
  • About Arma
  • Sector Expertise
  • Capabilities
  • Global Reach
  • Deals
  • Team
  • Arma Angle
  • News
  • Careers
  • Social Impact
  • Contact

Arma Partners LLP is authorised and regulated by the Financial Conduct Authority and registered as a limited liability partnership in England and Wales (registered number OC307424. VAT registered number 162087808).

  • Privacy Notice
  • Terms & Conditions of Use
  • Regulatory Disclosure
  • Modern Slavery Act Statement
  • Sustainability
  • Sitemap
  • Employee Privacy Notice

US Arma Partners LP is a FINRA member.

You can check the background of US Arma Partners LP and its registered representatives on FINRA’s BrokerCheck.

Copyright © 2025 Arma Partners Site produced by Skylark